These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 15184544)

  • 21. Immunization with the conjugate vaccine Vi-CRM₁₉₇ against Salmonella typhi induces Vi-specific mucosal and systemic immune responses in mice.
    Fiorino F; Ciabattini A; Rondini S; Pozzi G; Martin LB; Medaglini D
    Vaccine; 2012 Sep; 30(43):6111-4. PubMed ID: 22705173
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Small alarmones (p)ppGpp regulate virulence associated traits and pathogenesis of Salmonella enterica serovar Typhi.
    Dasgupta S; Das S; Biswas A; Bhadra RK; Das S
    Cell Microbiol; 2019 Aug; 21(8):e13034. PubMed ID: 31013389
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modulation of immune response and enhanced clearance of Salmonella typhi by delivery of Vi polysaccharide conjugate using PLA nanoparticles.
    Meena J; Kumar R; Singh M; Ahmed A; Panda AK
    Eur J Pharm Biopharm; 2020 Jul; 152():270-281. PubMed ID: 32470636
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An evaluation of purified Salmonella Typhi protein antigens for the serological diagnosis of acute typhoid fever.
    Tran Vu Thieu N; Trinh Van T; Tran Tuan A; Klemm EJ; Nguyen Ngoc Minh C; Voong Vinh P; Pham Thanh D; Ho Ngoc Dan T; Pham Duc T; Langat P; Martin LB; Galan J; Liang L; Felgner PL; Davies DH; de Jong HK; Maude RR; Fukushima M; Wijedoru L; Ghose A; Samad R; Dondorp AM; Faiz A; Darton TC; Pollard AJ; Thwaites GE; Dougan G; Parry CM; Baker S
    J Infect; 2017 Aug; 75(2):104-114. PubMed ID: 28551371
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunological evaluation of Vi capsular polysaccharide of Salmonella enterica subsp. Typhi vaccine by serum bactericidal assay.
    Ahmadi H; Tabaraie B; Maleknia S; Shapouri R; Nejati M; Pour Mirza Gholi F; Hedayati M; Sadati M; Zahednia S; Sharifat Salmani A
    J Med Microbiol; 2013 Feb; 62(Pt 2):283-286. PubMed ID: 23105026
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Production of monoclonal antibodies to Vi polysaccharide antigen of Salmonella typhi.
    Pongsunk S; Sarasombath S; Ekpo P; Tangtherawattana P; Levine MM
    Asian Pac J Allergy Immunol; 1993 Jun; 11(1):53-6. PubMed ID: 8216560
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Specific and cross-reactive immune response to oral Salmonella Typhi Ty21a and parenteral Vi capsular polysaccharide typhoid vaccines administered concomitantly.
    Pakkanen SH; Kantele JM; Savolainen LE; Rombo L; Kantele A
    Vaccine; 2015 Jan; 33(3):451-8. PubMed ID: 25433216
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Engineering, conjugation, and immunogenicity assessment of Escherichia coli O121 O antigen for its potential use as a typhoid vaccine component.
    Wetter M; Kowarik M; Steffen M; Carranza P; Corradin G; Wacker M
    Glycoconj J; 2013 Jul; 30(5):511-22. PubMed ID: 23053636
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Salmonella typhi Vi conjugate vaccine.
    Koul PA
    N Engl J Med; 2001 Aug; 345(7):545-6. PubMed ID: 11519517
    [No Abstract]   [Full Text] [Related]  

  • 30. Isotypes of human vaccinal antibodies to the Vi capsular polysaccharide of Salmonella typhi.
    Brugier JC; Barra A; Schulz D; Preud'homme JL
    Int J Clin Lab Res; 1993; 23(1):38-41. PubMed ID: 8477090
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Persistent efficacy of Vi conjugate vaccine against typhoid fever in young children.
    Mai NL; Phan VB; Vo AH; Tran CT; Lin FY; Bryla DA; Chu C; Schiloach J; Robbins JB; Schneerson R; Szu SC
    N Engl J Med; 2003 Oct; 349(14):1390-1. PubMed ID: 14523155
    [No Abstract]   [Full Text] [Related]  

  • 32. Terminal Deoxynucleotidyl Transferase Is Not Required for Antibody Response to Polysaccharide Vaccines against Streptococcus pneumoniae and Salmonella enterica Serovar Typhi.
    Belde V; Cravens MP; Gulandijany D; Walker JA; Palomo-Caturla I; Alugupalli AS; Sandilya VK; Mahmoud T; Bäumler AJ; Kearney JF; Alugupalli KR
    Infect Immun; 2018 Sep; 86(9):. PubMed ID: 29967094
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A recombinant protein of Salmonella Typhi induces humoral and cell-mediated immune responses including memory responses.
    Das S; Chowdhury R; Ghosh S; Das S
    Vaccine; 2017 Aug; 35(35 Pt B):4523-4531. PubMed ID: 28739115
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vivo characterization of the murine intranasal model for assessing the immunogenicity of attenuated Salmonella enterica serovar Typhi strains as live mucosal vaccines and as live vectors.
    Pickett TE; Pasetti MF; Galen JE; Sztein MB; Levine MM
    Infect Immun; 2000 Jan; 68(1):205-13. PubMed ID: 10603389
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An Unmutated IgM Response to the Vi Polysaccharide of
    Pandya KD; Palomo-Caturla I; Walker JA; K Sandilya V; Zhong Z; Alugupalli KR
    J Immunol; 2018 Jun; 200(12):4078-4084. PubMed ID: 29743315
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vi-Suppressed wild strain Salmonella typhi cultured in high osmolarity is hyperinvasive toward epithelial cells and destructive of Peyer's patches.
    Zhao L; Ezak T; Li ZY; Kawamura Y; Hirose K; Watanabe H
    Microbiol Immunol; 2001; 45(2):149-58. PubMed ID: 11293481
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Salmonella typhi O-polysaccharide--tetanus toxoid conjugated vaccine.
    Saxena M; Di Fabio JL
    Vaccine; 1994 Aug; 12(10):879-84. PubMed ID: 7526567
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immune responses to an oral typhoid vaccine strain that is modified to constitutively express Vi capsular polysaccharide.
    Tacket CO; Pasetti MF; Sztein MB; Livio S; Levine MM
    J Infect Dis; 2004 Aug; 190(3):565-70. PubMed ID: 15243933
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vivo regulation of the Vi antigen in Salmonella and induction of immune responses with an in vivo-inducible promoter.
    Janis C; Grant AJ; McKinley TJ; Morgan FJ; John VF; Houghton J; Kingsley RA; Dougan G; Mastroeni P
    Infect Immun; 2011 Jun; 79(6):2481-8. PubMed ID: 21402763
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of two Salmonella typhimurium hybrids as challenge organisms in a system for the assay of typhoid vaccines.
    Johnson EM; Diena BB; Lior H; Ryan A; Krol P; Baron LS
    Infect Immun; 1982 Oct; 38(1):201-5. PubMed ID: 6754614
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.